Oloumi A, Syam S, Dedhar S
British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Oncogene. 2006 Dec 14;25(59):7747-57. doi: 10.1038/sj.onc.1209752. Epub 2006 Jun 26.
The Wnt gene family encodes secreted signaling molecules that play important roles in tumorgenesis and embryogenesis. The canonical Wnt signaling pathway regulates target gene expression via the stabilization and nuclear translocation of the cytoplasmic pool of beta-catenin. The activation of integrin-linked kinase (ILK) is also known to regulate the stabilization and subsequent nuclear translocation of beta-catenin in several epithelial cell models. We now report that molecular and pharmacological inhibition of ILK activity in mammalian cells directly modulates Wnt signaling by suppressing the stabilization and nuclear translocation of beta-catenin, as well as beta-catenin/Lef-mediated transcription. Inhibition of ILK activity, but not phosphatidylinositol-3 kinase (PI3K) or MEK activities suppresses nuclear beta-catenin stabilization in cells stably expressing Wnt3a as well as in cells exposed to either Wnt3a conditioned media or purified Wnt3a. Furthermore, ILK inhibition reverses the Wnt3a-induced suppression of beta-catenin phosphorylation that accompanies beta-catenin stabilization. In addition, we show that ILK can be identified in a complex with Wnt pathway components such as adenomatous polyposis coli and GSK-3. Upon treatment of L cells with Wnt3a-CM, glycogen synthase kinase-3 (GSK-3beta) becomes highly phosphorylated on Ser 9, which is completely abolished upon inhibition of ILK activity. However, acute exposure of L cells to purified Wnt3a does not result in the stimulation of GSK-3beta Ser 9 phosphorylation, despite beta-catenin stabilization. Together our data demonstrate that ILK activity can modulate acute Wnt3a mediated beta-catenin phosphorylation, stabilization and nuclear activation in a PI3K-independent manner, as well as the more prolonged PI3K-dependent secondary effects of Wnt signaling on GSK-3 phosphorylation. Finally, we suggest that a novel small molecule inhibitor of ILK, QLT-0267, may be a useful tool in the regulation of pathological Wnt signaling.
Wnt基因家族编码分泌型信号分子,这些分子在肿瘤发生和胚胎发育中发挥重要作用。经典的Wnt信号通路通过β-连环蛋白胞质池的稳定和核转位来调节靶基因表达。在几种上皮细胞模型中,整合素连接激酶(ILK)的激活也已知可调节β-连环蛋白的稳定和随后的核转位。我们现在报告,在哺乳动物细胞中对ILK活性进行分子和药理学抑制可通过抑制β-连环蛋白的稳定和核转位以及β-连环蛋白/Lef介导的转录来直接调节Wnt信号。抑制ILK活性而非磷脂酰肌醇-3激酶(PI3K)或MEK活性可抑制稳定表达Wnt3a的细胞以及暴露于Wnt3a条件培养基或纯化Wnt3a的细胞中的核β-连环蛋白稳定。此外,ILK抑制可逆转Wnt3a诱导的伴随β-连环蛋白稳定的β-连环蛋白磷酸化抑制。另外,我们表明ILK可在与Wnt通路成分如腺瘤性息肉病大肠杆菌和GSK-3形成的复合物中被鉴定出来。用Wnt3a-CM处理L细胞后,糖原合酶激酶-3(GSK-3β)在Ser 9处高度磷酸化,而在抑制ILK活性后这一现象完全消失。然而,L细胞急性暴露于纯化的Wnt3a尽管β-连环蛋白稳定,但并未导致GSK-3β Ser 9磷酸化的刺激。我们的数据共同表明,ILK活性可独立于PI3K调节急性Wnt3a介导的β-连环蛋白磷酸化、稳定和核激活,以及Wnt信号对GSK-3磷酸化的更持久的PI3K依赖性次级效应。最后,我们认为一种新型的ILK小分子抑制剂QLT-0267可能是调节病理性Wnt信号的有用工具。